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ABSTRACT:
Introduction: Surgical site infection is a common complication shown in literature following cholecystectomies. 
Smaller incision and use of trocars in laparoscopic cholecystectomy lessen the contamination resulting in less chances 
of surgical site infection. However, in fear of postoperative infection, many opt for the prolonged postoperative 
use of antibiotic and there is growing consensus against it. Antibiotics not only increases the cost and hospital stay 
duration but it aids in emergence of multidrug resistance. Because of the controversies, we conducted this clinical 
trial to see whether a single prophylactic dose of antibiotic at the time of induction of anesthesia for laparoscopic 
cholecystectomy was equally effective in controlling post-operative infection as multi-dose antibiotics during and 
post-operative period. Methods: The study was conducted at the department of general surgery, Lumbini Medical 
College Teaching Hospital, from November  2015 to October 2016. All cases with symptomatic cholelithiasis 
subjected for laparoscopic cholecystectomy were enrolled. Patients were randomized into two groups; Group SD 
received single dose of an intravenous dose of amikacin 500 mg, at induction of anesthesia and Group MD received 
multiple intravenous dose of amikacin, during and postoperatively for two days. Complications, hospital stay, and 
treatment cost in two groups were compared and analyzed. Results: There were a total of 240 patients in the study, 
118 in Group SD and 122 in Group MD. Post-operative infection rate was 4.2% (n= 5, N=118) in Group SD and 
3.3% (n=4, N=122) in Group MD; the difference was not significant (p=0.75). Hospital stay was prolonged and cost 
was higher significantly in Group MD. Conclusion: Single dose of prophylactic antibiotic, administered at induction 
of anesthesia, is equally effective as multiple doses of post surgical antibiotics to prevent post-operative infection in 
patients undergoing elective laparoscopic cholecystectomy for uncomplicated cholelithiasis. 
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INTRODUCTION:
At present, laparoscopic cholecystectomy is gold standard for treatment of symptomatic 
gallstone. The role of prophylactic antibiotic in 
various clean or clean contaminated surgery reduce 
the risk of postoperative infective complication 
thereby reducing morbidity and mortality. 
Antibiotic prophylaxis are clearly not indicated 
for most patients undergoing straightforward clean 
surgical operations in which no obvious bacterial 
contamination or insertion of a foreign body has 
occurred.[1] However, clinicians do not give up 
the tradition of using postoperative antibiotics 
despite recent evidences supporting single dose 
prophylactic antibiotic use over multiple doses of 
antibiotics during and after surgery. A study done in 
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our center had shown that amikacin was the most 
sensitive antibiotic against organisms in bile culture 
of symptomatic gallstone patients.[2] The over-use 
of antibiotics can result in more adverse effects, rise 
in emergence of drug resistant organisms, as well as 
increased treatment cost.[3] It is not clear whether 
postoperative use of antibiotic in laparoscopic 
cholecystectomy, for uncomplicated cholelithiasis 
and complicated cholelithiasis without features of 
organ failure, is of any advantage to the patient in 
terms of preventing infection. The present study 
aims to evaluate whether single dose of prophylactic 
antibiotic, administered at induction of anesthesia, is 
equally effective as multiple doses of post-surgical 
antibiotics to prevent post-operative infection 
in patients undergoing elective laparoscopic 
cholecystectomy for uncomplicated cholelithiasis. 
METHODS:
 A randomized controlled trial was conducted 
at Lumbini Medical College Teaching Hospital 
(LMCTH) from first of November 2015 to 31st 
of October 2016. The study was approved by the 
institutional review committee of the college (IRC-
LMC). All patients suffering from symptomatic 
documented gallstones on ultrasonography and 
undergoing laparoscopic cholecystectomy were 
included in the study. Patients with complicated 
gall stones (cholangitis, choledocholithiasis, and 
pancreatitis) and those who required conversion 
to open cholecystectomy were excluded. Acute 
cholecystitis with high leukocyte count (>15,000/
mm3) and fever (>100°F) prior to surgery were 
excluded. Patients who were found to have 
suppurative cholecystitis, empyema, or gangrenous 
gallbladder during surgery were also excluded. 
However, patients with acute biliary attack of 
right upper quadrant pain of less than a week with 
leukocyte count ≤15,000/mm3, fever ≤100°F, and 
without features of organ failure, were included in 
the study. Those who did not consent to be included 
in the study were excluded.
 All the patients were examined and 
investigated prior to their surgery, and the information 
needed was recorded. Before surgery, patients were 
subjected for simple sequential randomization where 
an opaque container containing 10 small cheats 
with number one to 10 written inside it were made. 
Patient was asked to withdraw one cheat blindly by 
operating room anesthetic assistant. The cheat was 
returned back to the same container for next patient. 
Same process was repeated for each patient. Odd-
numbered (1,3,5,7,9) patients received single dose 
antibiotic prophylaxis (Group SD) of injection 
amikacin 500mg (AMIKATIL) at induction of 
anesthesia, whereas even numbered (2,4,6,8,10) 
received antibiotic prophylaxis of injection amikacin 
500 mg (AMIKATIL) at induction of anesthesia and 
continued at same dose twice a day postoperatively 
for  two days (Group MD). Operation-room anesthetic 
assistant administered prophylactic antibiotics at 
induction of anesthesia to all the patients. Group 
MD patients received additional doses in the ward 
from ward nurses. 
 All LCs were performed under general 
anesthesia with endotracheal intubation by the 
surgeons experienced in the procedure. The 
abdominal skin was prepared with 10% povidone-
iodine solution. Laparoscopic instruments were 
sterilized as per hospital protocol before procedures 
(overnight dipping in Suma Med Enzyme, a special 
enzymatic liquid detergent formulated to elimination 
of dirt in the cleaning of medical instruments in soft-
medium water; and dipping in 2% gluteraldehyde 
one hour before surgery). Aseptic precaution 
was maintained throughout the procedure. After 
dissection of gall bladder from GB fossa, epigastric 
port was used for extraction of gall bladder; those 
found difficult due to thick wall or large stone size 
for extraction were retrieved through umbilical port. 
Patients were monitored postoperatively in recovery 
room for two hours and then send to post anesthesia 
care unit as per our existing practice. 
 For postoperative analgesia, injection 
ketorolac 30 mg intravenously, every eight hours, 
was administered on the day of operation, and 
was switched to oral combination of paracetamol 
500 mg and ibuprofen 400 mg from next day. Oral 
feeding was started after six hours of surgery. Drip 
was stopped once oral feeding was tolerated with 
cannula being locked in situ. Patients in Group SD 
were discharged on second postoperative day after 
first dressing if vitals were stable, no features of 
peritonitis was present, and patients tolerated oral 
feeds. Patients on Group MD were discharged on 
third postoperative day after receiving antibiotics for 
48 hours. Patients from both groups were advised 
to follow up in surgical out-patient clinic on eight 
post operative day for suture removal and 30th 
postoperative day with reports of histopathology 
of resected gallbladder. Status of wound (normal, 
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inflamed, or pus) was recorded and managed 
accordingly with anti-inflammatory drugs thrice 
daily for inflammation and dressing of wound in case 
of pus. Pus was subjected for culture and sensitivity 
testing. 
 Patient’s demographics and clinical 
characteristics including gall bladder perforation and 
bile/stones spillage during surgery, use of suction, 
status of wound were recorded in a pre-designed 
proforma. Data were entered into Microsoft Excel 
2013 and were analyzed with SPSS-23. Descriptive 
statistics was presented as mean, standard deviation, 
frequency, and percentage. Student-t test was used 
to compare continuous data, Chi-square test was 
used to compare categorical data. P value of 0.05 
was considered significant.
RESULTS:
 A total of 240 patients were included in the 
study. There were 118 (49.2%) patients in Group 
SD and 122 (50.8%) in Group MD. Mean age of 
patients in Group SD and Group MD was 44.19 year 
(SD=16.18) and 51.31 year (SD=14.50) respectively. 
This difference in mean was statistically significant 
(t=3.59, df=238, p<0.001) with patient in Group 
SD being younger than those in Group MD. There 
were 71.2% (n=84, N=118) female in group SD and 
54.9% (n=67, N=122) female in Group MD and this 
difference was statistically significant (X2[N=240, 
df=1] = 6.8, p=0.009). Twenty-four patients in total 
presented with features of acute biliary attack. Seven 
of them were in Group SD and 17 in Group MD 
and this difference was statistically not significant 
(X2[N=24, df=1] = 2.2, p=0.24). Intra-operative 
biliary spillage was seen in 18.6% (n=22, N=118) in 
Group SD and 21.3% (n=26, N=122) in Group MD. 
This difference was comparable (X2[N=240, df=1] = 
0.27, p=0.6). Port contamination was more common 
(8.5%, n=10, N=118) in Group SD as compared 
to Group MD (4.1%, n=5, N=122), however the 
difference was not significant (X2[N=240, df=1] = 
1.96, p=0.19). Duration of surgery was comparable 
in two groups (t=0.79, df=238, p=0.43). Mean 
duration in Group SD was 42.84 min (SD=28.66) 
and in Group MD was 40.12 min (SD=24.67). Mean 
length of hospital stay in Group MD (M=3.15 days, 
SD=0.36) was significantly longer (t=32.47, df=238, 
p<0.001) than that in Group SD (M=2.02 days, 
SD=0.13). Average treatment cost in Group MD 
was NRs 28973.89 (SD=557.55) and for patients 
in Group SD was NRs 23320.55 (SD=503.77); 
treatment cost was significantly higher in Group MD 
(t=82.33, df=238, p<0.001).  
 Table 1 shows the rate of surgical site 
infections in two groups, the difference was not 
statistically significant. All infections occurred at 
epigastric port except one in the Group SD which 
occurred in umbilical port. The later was managed 
with stitch removal, laying open of the wound, 
collection of swab for culture and sensitivity, anti-
inflammatory drug, but no empirical antibiotic. 
Culture did not reveal any growth of micro-organisms. 
Daily dressing was followed by secondary suturing 
on the third post-operative day. 
Table 1: Wound infection between two groups
Wound 
infection, 
n (%)
No wound 
infection, 
n (%)
p 
Group SD (n=118) 5 (4.24%) 113 (95.76%) 0.75
(Fisher 
exact)Group MD (n=122) 4 (3.28%) 118 (96.72%)
 Wound erythema was seen in equal number 
in both group (n=4 each) and managed with oral 
anti-inflammatory drugs. Most of the case with 
wound erythema (n=3) and stitch abscess (n=1) 
might had port contamination during delivery of 
GB from the epigastric port. Patient with stitch 
abscess has associated controlled hypothyroidism. 
No patient of either group developed deep infection, 
seroma formation, or other complications. None of 
the patient developed any complication in a follow 
up period of one month.
 Among diabetic patients, 44.4% (n=4, N=9) 
developed postoperative wound infection whereas 
only 2.1% developed infection among non-diabetic 
patients. This difference was significant (p<0.001, 
Fisher exact test).
 Table 2 shows the relationship between 
diabetes status and treatment group among those 
patients who developed postoperative surgical site 
infection. There was no significant association 
between the presence of wound infection in diabetes 
in patients receiving single dose of antibiotic 
compared to those receiving multiple dose antibiotic. 
Table 2: Infection in two group and diabetes status
Group SD Group MD P
DM with infection 1 3 0.2
Fisher 
exactNon DM with infection 4 1
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DISCUSSION:
 Surgical site infection is presumed to 
be a common problem associated with clean-
contaminated and contaminated surgical procedures. 
SSI increases hospital stay, hospital cost and patient 
morbidity and mortality. The use of prophylactic 
antibiotic is believed to make the surgical outcome 
better and has been a trend ever since the era prior to 
the introduction of minimal invasive Laparoscopic 
cholecystectomy two decades ago. Laparoscopic 
cholecystectomy is an elective clean operation with 
very low post-operative wound infection rate.[4,5] 
In Laparoscopic cholecystectomy, the incision is 
smaller and manipulation is done through trocars 
that lessen the contamination and exposure of 
wound, unlike in open surgery.[6,7] Secondly, the 
better preservation of immune system following 
less tissue trauma and  non-violation of mucosal 
defense barrier of the respiratory, gastro-intestinal or 
genital epithelium lessen the incidence of infections 
following laparoscopic cholecystectomy; the need 
for postoperative antibiotics is now frequently 
questioned.[8] The main aim of our study is to 
evaluate the impact of single dose versus multiple 
dose antibiotics in preventing postoperative SSI 
in elective laparoscopic cholecystectomy. All 
cholecystectomy patients at our hospital routinely 
receive antibiotic prophylaxis (amikacin 500 mg IV) 
prior to surgery.[2]  
 The mean age in our study was 44 years in 
patient receiving single dose antibiotics and 51 years 
in patient receiving multiple dose of antibiotics. 
There should have been no significant difference 
in the mean age between randomized groups. We 
don't have a clue on how that happened. Maybe this 
was due to simple randomization. This is one of the 
weakness of this study. 
 In the present study, the SSI was slightly 
higher in Group SD but it was not significantly 
different. Our findings are comparable with reported 
studies.[6,9-11] In a randomized controlled trial by 
Gaur et al. on 417 patients undergoing laparoscopic 
cholecystectomy, an overall infection rate was 2.2%, 
which is consistent with the results obtained in our 
study.[12] 
 In the present study, we had higher incidence 
of bile spillage (20%, n=48, N=240). Possible 
cause could be involvement of acute cases (10%) 
and different levels of operating surgeons, though 
all of them were experienced about the procedure. 
Findings of this study does not support the general 
perception that bile leak increases the SSI. Out of 22 
bile spillage in Group SD (118 LC), there were only 
five SSIs, out of which only three had intraoperative 
bile spillage. Similarly, in Group MD (122 LC), there 
were 26 bile spills, but none of the four SSIs had 
any history of bile spill. Other studies have reported 
similar findings.[13,14] We did not include body 
mass index (BMI) as a possible variable to influence 
wound infection in open surgery, because BMI is 
not considered a risk factor in minimal invasive 
LC with small incision. In case of LC, studies have 
not found differences in operative time, length of 
stay, or complications between normal-weight and 
overweight or obese patients.[15]
 There was significant difference in average 
hospital stay after surgery, with 2.02 days in Group 
SD and 3.15 days in Group MD. Our practice is to 
discharge patients on the second postoperative day 
following LC unless their condition was complicated 
(example: unstable vitals or peritonitis due to bile 
leak) or they were not willing to go home (due to 
transportation problem when living far from the 
hospital). In this study, we had no bile leak or duct 
injury. Our hospital policy is to admit patients for 
elective surgery one day prior to surgery for pre-
anesthetic checkup. In Group MD patients, we 
give antibiotics post-operatively for 48 hours, so 
they have to stay longer than patients in Group SD. 
Because of the longer hospital stay and the cost of 
antibiotic for 48 hours, the average treatment cost 
for patients in Group MD was significantly higher.
 There are some limitations in the study; as 
we did not include patients with acute cholecystitis 
with high leukocyte count (TLC>15000/mm3), 
fever on admission (Temp.>100°F), or findings of 
suppurative cholecystitis, empyema, or gangrenous 
gallbladder during surgery. Thus, these findings 
cannot be generalized to all patients who undergo 
surgery for acute cholecystitis because they are 
already on antibiotic when admitted from emergency 
department. This will require separate study. 
Admitted patients at our institute are subjected for 
cholecystectomy within a week of attack, on any of 
the six scheduled operation days. Otherwise, they 
are advised for surgery after six weeks or more. We 
consider “emergency cholecystectomy surgery” out 
of normal operating schedule only if suspicious for 
complication such as peritonitis due to gangrenous 
or gallbladder perforation. 
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 As the risk of SSI in LC is low, so even 
for uncomplicated cases of acute cholecystitis 
(TLC ≤ 15000 with temp. ≤ 100°F), single dose of 
prophylactic antibiotics will suffice, as we found 
in this study. Based on recent published evidences 
and after the completion of our own study, we 
have now adopted the policy of not administering 
postoperative antibiotics in uncomplicated cases of 
LC. This study is hoped to help other institutions in 
Nepal as well as in other developing countries with 
similar socioeconomic condition to benefit from its 
findings.
CONCLUSIONS:
 For laparoscopic cholecystectomy, a single 
dose of prophylactic antibiotic, administered at the 
time of induction of anesthesia, is equally effective 
in reducing the surgical site infection as compared to 
multiple intra and post-operative doses of antibiotics 
in patients undergoing elective laparoscopic 
cholecystectomy for uncomplicated cholelithiasis 
and those with marginally raised leukocytes and 
low-grade fever. Post-operative continuation of 
antibiotics only increases the treatment cost and 
hospital stay without any effect on SSI.
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